Latest news

Thumbnail image for FDA grants Keytruda priority review

FDA grants Keytruda priority review

If approved by the FDA, this would mark the third indication for Keytruda in metastatic NSCLC in the United States based on OS data

1st May 2018

Thumbnail image for FDA approval for Novartis' melanoma combo

FDA approval for Novartis' melanoma combo

Tafinlar/Mekinist combo is the first oral targeted adjuvant combination therapy to demonstrate significant clinical benefit in patients with a BRAF V600 mutation

1st May 2018

Thumbnail image for Clinical Researcher of the Year – The Americas: Winners announced!

Clinical Researcher of the Year – The Americas: Winners announced!

The winners of the 2018 PharmaTimes Clinical Researcher of the Year competition were announced at an awards ceremony and gala dinner last night. It followed a day of fierce competition at the Regency Hyatt, in which 55 individual finalists and 16 teams battled it out for the coveted pharma in each of their respective categories.

30th April 2018

Thumbnail image for US priority review for Sanofi, Regeneron’s cemiplimab

US priority review for Sanofi, Regeneron’s cemiplimab

US regulators are undertaking a priority review of Sanofi and Regeneron’s cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC), or those with locally advanced CSCC who are not candidates for surgery.

30th April 2018

Thumbnail image for Three medicines step closer to EU approval

Three medicines step closer to EU approval

Three medicines treating HIV, pain and cancer have been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) at its latest meeting.

30th April 2018

Previous  --   12 13 14 15 16 17 18 19 20 21   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download